We provide you with 20 years of free, institutional-grade data for INMD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of INMD. Explore the full financial landscape of INMD stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about INMD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
InMode Ltd(NASDAQ:INMD) 
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various pr...
Website: https://www.inmodemd.com
Founded: 2008
IPO Price: $14 (Aug 08, 2019)
Full Time Employees: 251
CEO / Co-Founder: Moshe Mizrahy
Sector: Healthcare
Industry: Medical Devices